| CTRI Number |
CTRI/2024/09/073964 [Registered on: 17/09/2024] Trial Registered Prospectively |
| Last Modified On: |
28/11/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Preventive |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
"Comparing the Effects of Ketamine and Etomidate on Eye Nerve Size to Check Brain Pressure in Head Injury Patients Needing Intubation in the Emergency Room" |
|
Scientific Title of Study
|
Effect of Etomidate and Ketamine on Optic Nerve Sheath Diameter in severe Traumatic Brain Injury patients undergoing Rapid Sequence Intubation in Emergency Department: ARandomized Controlled Trial. |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr P Santhosh |
| Designation |
Post Graduate Student |
| Affiliation |
AIIMS,BHUBANESWAR |
| Address |
Trauma and Emergency Office
New Trauma Building
Department of Trauma & Emergency
All India Institute Of Medical Sciences
Bhubaneswar
Room no. 405
New Trauma Building
Department of Trauma & Emergency
All India Institute Of Medical Sciences,Bhubaneswar
Sijua Khordha ORISSA 751019 India |
| Phone |
7603820760 |
| Fax |
|
| Email |
santhoshsp2015@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Subhasree Das |
| Designation |
Assistant Professor |
| Affiliation |
AIIMS,Bhubaneswar |
| Address |
Trauma and Emergency Office
New Trauma Building
Department of Trauma & Emergency
All India Institute Of Medical Sciences
Bhubaneswar
Khordha ORISSA 751019 India |
| Phone |
7978885193 |
| Fax |
|
| Email |
drkakalee@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Subhasree Das |
| Designation |
Assistant Professor |
| Affiliation |
AIIMS,Bhubaneswar |
| Address |
Trauma and Emergency Office
New Trauma Building
Department of Trauma & Emergency
All India Institute Of Medical Sciences
Bhubaneswar
Khordha ORISSA 751019 India |
| Phone |
7978885193 |
| Fax |
|
| Email |
drkakalee@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
NA |
| Address |
NIL |
| Type of Sponsor |
Other [NIL] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Subhasree Das |
AIIMS Bhubaneswar |
Department of Trauma and Emergency
(Emergency department red-yellow zone)
AIIMS Bhubaneswar
Sijua,Patrapada Khordha ORISSA |
7978885193
drkakalee@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| INSTITUIONAL ETHICS COMMITTEE,AIIMS BHUBANESWAR |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: S061||Traumatic cerebral edema, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Etomidate 0.3-0.5 mg/kg IV |
Patients with traumatic brain injury who fit in inclusion criteria will receive Etomidate 0.3-0.5 mg/kg IV for RSI. USG guided Optic Nerve Sheath Diameter will be measured 3mm posterior to optic disc 3 min prior to the drug administration and at 5 minutes and 10 min after drug administration to check for dynamic
changes. |
| Intervention |
Ketamine 1-2 mg/kg IV |
Patients with traumatic brain injury who fit ininclusion criteria will receive Ketamine 1-2 mg/kg IV for RSI. USG guided Optic Nerve Sheath Diameter will be measured 3mm posterior to the optic disc 3min
prior to the drug administration and at 5 minutes and 10 min after drug administration to check for dynamic
changes. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
62.00 Year(s) |
| Gender |
Both |
| Details |
With traumatic brain injury
presenting to ED and requiring a rapid sequence
intubation.
Patient relatives are willing to participate in the study |
|
| ExclusionCriteria |
| Details |
Hemodynamic instability( hyper or hypotension)
during RSI
Predicted difficult intubation by LEMON scoring
Patients with open skull injuries
Patients with eyeball globe injuries, orbital mass or
tumors.
Patients with H/O any neurosurgical procedures.
Nontraumatic brain injuries
pregnancy
Anti-edema therapy like Mannitol infusion started
before arrival at ED
Contraindication or Hypersensitivity to any used
drug.
• Other organ injury causing likelihood of low GCS |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
Average change in optic nerve sheath diameter before and after
administration of induction drugs |
Parameters Wii be taken 3 minutes before induction ,5 and 10 minutes following induction.The patient will be followed up for next 24 hour. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1. Hemodynamic changes
2. Successful first pass intubation
rates
3.To check the duration of sedative efficacy among the two groups. |
Measurements are taken just before induction and 5 minutes, 10 minutes following induction. |
|
|
Target Sample Size
|
Total Sample Size="62" Sample Size from India="62"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Post Marketing Surveillance |
|
Date of First Enrollment (India)
|
26/09/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
26/09/2024 |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Traumatic Brain Injury(TBI) has been one of the leading causes of morbidity and mortality all around the. world. During airway management in TBI, there are chances of an increase in Intracranial pressure (ICP) due to intubation, hypoxia, and hemodynamic instability.ICP is highly dynamic and changes instantly during intubation. In the literature, there is no specific drug that provides ideal incubating conditions for acute TBI patients. To provide sedation before the procedure Etomidate has long been the drug of choice. However, Etomidate causes adrenal suppression and increases the risk of morbidity and mortality. Ketamine has emerged as a drug of choice in many such patients recently since it does not cause hypotension, has analgesic properties and its cerebral protection effect is being studied. Ultrasonography of optic nerve sheath diameter (ONSD) has been correlated with an increase in ICP as an optic nerve sheath. However, there are no studies in the literature comparing the efficacy of these drugs on ICP changes in acute TBI patients. This study will compare both these drugs and provide a better option of induction agent for rapid sequence intubation in traumatic brain injury patients. |